SOLICITATION NOTICE
B -- Salivary Nitrosoproline in China
- Notice Date
- 8/30/2005
- Notice Type
- Solicitation Notice
- NAICS
- 541710
— Research and Development in the Physical, Engineering, and Life Sciences
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Research Contracts Br., 6120 Executive Blvd. EPS Suite 600, Rockville, MD, 20852
- ZIP Code
- 20852
- Solicitation Number
- NCI-50159-NG
- Response Due
- 9/9/2005
- Archive Date
- 9/24/2005
- Description
- The National Cancer Institute (NCI) Division of Cancer Epidemiology and Genetics (DCEG), plans to procure on a sole source basis, services regarding: Salivary nitrosoproline in China, with the Eppley Institute for Research in Cancer, University of Nebraska Medical Center, Omaha, NE 68198-6805. The supplies and services herein are being procured in accordance with the simplified acquisition procedures authorized by FAR Part 13. The North American Industry Classification System code is 541710 and the business size standard is 500 employees. Esophageal cancer is one of the leading causes of death in many countries around the world. The NCI Nutritional Epidemiology Branch (NEB) conducts intramural research in the areas of nutrition and cancer, genetics and cancer, and cancer prevention. The NEB NCI is currently examining the hypothesis that salivary nitrosamine formation is associated with increased risk of esophageal cancer and that poor oral health increases the formation of nitrosamines in the saliva. Individual propensity to form nitrosamines will be assessed using a nitrosoproline phenotyping test. The purpose of this procurement is to obtain data on salivary nitrosoproline formation. This data will aid the NEB in the examination of a cross-sectional study of esophageal cancer in Linxian, China. The University of Nebraska shall determine Nitrosproline and N-nitrososarcosine concentration in 185 saliva samples from Linxian, China. The type of assay NCI requires is used in experimental studies only and is not used in any clinical setting. Therefore, only academic research labs can provide this specific work. The University of Nebraska Medical Center is the only source known in the United States that is currently running this assay, has the expertise, and has studied in vivo nitrosamine formation. This notice is not a request for competitive quotation. However, if any interested party believes it can meet the above requirement, it may submit a statement of capabilities. The statement of capabilities and any other information furnished must be in writing and must contain material in sufficient detail to allow NCI to determine if the party can perform the requirement. Capability statements must be received in the contracting office by 1:00 PM EDT, on September 9, 2005. For further information please contact Malinda Holdcraft, Contract Specialist via electronic mail at holdcram@exchange.nih.gov. A determination by the Government not to compete this proposed requirement based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. No collect calls will be accepted. No faxed or emailed capability statements will be accepted. In order to receive an award, contractors must be registered in the Central Contractor Registration (CCR) and the Online Representations and Certifications Applications (ORCA). Reference, NCI-50159-NG.
- Record
- SN00882399-W 20050901/050830211815 (fbodaily.com)
- Source
-
FedBizOpps.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |